Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06376565 · ClinicalTrials.gov registry record · NA
Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps
A NA study of Colorectal Carcinoma, sponsored by Jonsson Comprehensive Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 1,680
- Enrollment target
- 1
- Study location
NCT06376565: Recruiting NA study of Colorectal Carcinoma, sponsored by Jonsson Comprehensive Cancer Center.
NCT06376565 is a NA study of Colorectal Carcinoma that is actively recruiting participants, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 1,680 participants, above the 1,065-participant average among 53 other Colorectal Carcinoma trials with a reported enrollment target (58% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06376565, a NA study of Colorectal Carcinoma, is actively recruiting participants, sponsored by Jonsson Comprehensive Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,680 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial tests a multilevel intervention at the clinic, provider and patient levels, to improve colonoscopy surveillance in patients with high risk colon polyps. Colorectal cancer (CRC) is a common and deadly disease that is largely preventable through the detection and removal of colorectal polyps. One million Americans are diagnosed with high risk polyps of the colon or rectum annually and are at increased risk for CRC; however, uptake of recommended repeat colonoscopy in 3 years to reduce CRC risk is low in this group. This multilevel intervention may work to improve timely colonoscopy screening for patients with high risk colon polyps.
Primary Outcome
The Investigators will conduct 1-on-1 in-depth interviews with patients, advocates, providers, and administrators. these interviews will provide data in closer proximity to intervention implementation to optimize composition, timing, and acceptability of each component. Interview content is guided by the multiple health outcomes framework (MHOF) and addresses major barriers (patient, provider, system) to surveillance and challenges (patient, provider, system) to the planned implementation of int
Conditions Studied
Interventions
- OTHER Best Practice
- OTHER Communication Intervention
- OTHER Interview
Study Locations (1)
California
- UCLA / Jonsson Comprehensive Cancer Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,680 participants |
| Start Date | 2023-11-08 |
| Est. Completion | 2027-11-30 |
| Phase | NA |
What NCT06376565 shows while recruiting
NCT06376565 is an interventional study that assigns participants to a tested intervention. Its 1,680 participants enrollment target places it among the larger protocols in the corpus, above the 1,065-participant average among 53 other Colorectal Carcinoma trials with a reported enrollment target (58% higher).
The record links to 1 condition, with Colorectal Carcinoma appearing as the primary indexed condition, and to 3 interventions - of which Best Practice is the first listed.
NCT06376565 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06376565 about?
NCT06376565 is a clinical study titled "Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps". This clinical trial tests a multilevel intervention at the clinic, provider and patient levels, to improve colonoscopy surveillance in patients with high risk colon polyps. Colorectal cancer (CRC) is a common and deadly disease that is largely preventable through the detection and removal of colorec...
What is the current status of trial NCT06376565?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,680 participants. The study started on 2023-11-08. Estimated completion is 2027-11-30.
What conditions does trial NCT06376565 study?
This clinical trial studies the following conditions: Colorectal Carcinoma.
What interventions are being tested in trial NCT06376565?
The interventions under investigation include: Best Practice (OTHER), Communication Intervention (OTHER), Interview (OTHER).
Who is sponsoring clinical trial NCT06376565?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06376565 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06376565's enrollment target sits among peer trials
1,680 7th of 53 higher than 47 of 53 other Colorectal Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colorectal Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)
RECRUITING · NA
-
Confronting Cancer as a Community
RECRUITING · NA
-
CoGENES Randomized Controlled Trial (RCT)
RECRUITING · NA
-
A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers
RECRUITING · NA
-
Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors
RECRUITING · NA
-
A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04852887 · 1,670 participants · Phase 3
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- NCT06644625 · 1,665 participants
CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study
- NCT06034405 · 1,663 participants
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
- NCT04321200 · 1,700 participants
PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI